Dow Up 1.31% Nasdaq Up 2.40%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.68 1.68(4.80%) Oct 21, 4:00PM EDT
|After Hours : 36.56 Down 0.12 (0.33%) Oct 21, 4:33PM EDT
Prev Close:35.00
Open:35.50
Bid:35.00 x 400
Ask:38.90 x 100
1y Target Est:39.00
Beta:0.77
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:35.11 - 37.53
52wk Range:20.02 - 42.50
Volume:1,580,056
Avg Vol (3m):766,308
Market Cap:2.67B
P/E (ttm):16.30
EPS (ttm):2.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNUp 4.80%2.67B
ABT63.74B

Key Statistics

Forward P/E (1 yr):16.52
P/S (ttm):3.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.89
Quarterly EPS Est (Sep-14) :0.33
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback